BCM
RMD icon

Brasada Capital Management’s ResMed RMD Stock Holding History

Brasada Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,437
Closed -$4.15M – 169
2026
Q1 		$4.15M Buy
18,437
+934
+5% +$233K 0.76% 56
2025
Q4 		$4.28M Buy
17,503
+1,024
+6% +$262K 0.72% 51
2025
Q3 		$4.56M Buy
16,479
+470
+3% +$128K 0.77% 47
2025
Q2 		$4.11M Buy
16,009
+298
+2% +$71.1K 0.7% 51
2025
Q1 		$3.21M Buy
+15,711
New +$3.67M 0.64% 53
2021
Q1 		– Sell
-6,142
Closed -$1.31M – 169
2020
Q4 		$1.31M Buy
6,142
+380
+7% +$75.8K 0.3% 72
2020
Q3 		$988K Sell
5,762
-205
-3% -$37.9K 0.25% 75
2020
Q2 		$1.15M Buy
5,967
+582
+11% +$95.2K 0.32% 71
2020
Q1 		$793K Buy
5,385
+143
+3% +$22.8K 0.28% 64
2019
Q4 		$812K Sell
5,242
-14
-0.3% -$2.02K 0.2% 86
2019
Q3 		$710K Buy
5,256
+87
+2% +$11.4K 0.19% 89
2019
Q2 		$640K Sell
5,169
-517
-9% -$57.3K 0.17% 100
2019
Q1 		$591K Buy
5,686
+51
+0.9% +$5.26K 0.18% 94
2018
Q4 		$642K Buy
+5,635
New +$604K 0.21% 83

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Brasada Capital Management's RMD Position: Q2 2026 in Review

Brasada Capital Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 18,437 shares — an estimated $4.15M sold.

Brasada Capital Management first reported a position in RMD in Q4 2018 and held it in 14 quarters. The position peaked at $4.56M in Q3 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Brasada Capital Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Brasada Capital Management sold 18,437 ResMed shares in Q2 2026, an estimated $4.15M.
  • Brasada Capital Management first reported a position in ResMed in Q4 2018 and held it in 14 quarters.
  • Brasada Capital Management's ResMed position peaked at $4.56M in Q3 2025.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Brasada Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.